Nuvini Achieves Complete Compliance with Nasdaq Requirements
Delisting Notice: Nuvini received a delisting determination from Nasdaq due to its ordinary shares closing below $1 for 30 consecutive business days, which violated Listing Rule 5550(a)(2). The company had until October 21, 2025, to appeal the decision.
Regained Compliance: As of October 20, 2025, Nuvini was notified by Nasdaq that it had regained compliance with the listing rule after its shares closed above $1 for 10 consecutive business days, thus resolving the delisting issue.
CEO Statement: Pierre Schurmann, Nuvini's CEO, expressed satisfaction with the compliance confirmation and highlighted the company's focus on long-term profitability and value creation.
Financial Outlook: Nuvini anticipates generating approximately R$50 to R$60 million in EBITDA for the twelve months ending December 31, 2025, excluding acquisition impacts.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on NVNI
About NVNI
About the author
Nuvini Welcomes AI Expert Phoebe Wang to Its Board of Directors
Appointment of Phoebe Wang: Nuvini Group Limited has appointed Phoebe Wang to its Board of Directors, effective November 14, 2025, bringing her extensive experience in AI and enterprise technology to the company.
Commitment to AI and Cloud Innovation: Wang's appointment aligns with Nuvini's recent partnership with Oracle, emphasizing the company's focus on integrating advanced AI and cloud capabilities to enhance its SaaS portfolio.
Strategic Goals: Nuvini aims to scale profitability and improve customer retention and operational efficiency through AI, with Wang's expertise expected to support these objectives.
Company Overview: Nuvini, headquartered in São Paulo, Brazil, is a leading acquirer of profitable B2B SaaS businesses in Latin America, focusing on creating value through strategic partnerships and operational expertise.
Nuvini Group Names Roberto Otero as CFO
New CFO Appointment: Nuvini Group Limited has appointed Roberto Otero as Chief Financial Officer, effective November 3.
Successor Details: Otero will replace Luiz Busnello, who will remain with the company as a board member after his transition from the CFO role.
Otero's Background: Prior to this appointment, Otero served as CFO of Eurofarma's International Operations, managing financial strategy and treasury across 23 countries.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
